Press Release – BioMark Continues to Strengthen its Intellectual Property position With New Patent
and Trademark Use in Canada
![biomark diagnostics patent](https://www.biomarkdiagnostics.com/wp-content/uploads/2022/06/biomark-diagnostics-patent.jpg)
BioMark Continues to Strengthen its Intellectual Property position With New Patent and Trademark Use in Canada Vancouver, British Columbia – (June 21st, 2022) – BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company developing molecular diagnostic tests with a focus on hard to detect and […]
BioMark Diagnostics Inc. Receives Full Registered Trademark Status from the US Patent and Trademark Office for its Company Brand Name “BioMark”
![biomark receives full registered trademark from USPTO](https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/biomark-receives-full-registered-trademark-from-USPTO.jpg)
Vancouver, British Columbia – (July 16, 2020) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) announced today that the Company has been granted a Full Registered Trademark Status from the US Patent and Trademark Office for its Company Brand Name “BioMark”. The term “BioMark” was selected by the company in reference to […]
BioMark Diagnostics presents at Rodman & Renshaw Conference in NY, USA
![BioMark Diagnostics presents at Rodman & Renshaw Conference in New York USA](https://www.biomarkdiagnostics.com/wp-content/uploads/2015/09/BioMark-Diagnostics-presents-at-Rodman-Reshaw-Conference-in-New-York-USA.jpg)
BioMark Diagnostics Inc. presents at Rodman & Reshaw Conference in New York, USA Follow these links for our audio presentation and corporate overview power point. Audio Presentation Powerpoint Presentation